From: Functional role of post-translational modifications of Sp1 in tumorigenesis
PTM | Modified sites | Modified enzymes | Functions | Ref. |
---|---|---|---|---|
Phosphorylation | Ser59 | CDK2 | Increase Sp1 DNA binding activity | [21] |
 | Ser101 | ATM | Involve in DNA damage and repair | [25] |
 | Ser131 | DNA-PK | Upregulate expression of the HIV-1 Tat protein. | [26] |
 | Thr266 | Ras-MAPK | Increase expression of apolipoprotein A-I | [27] |
 | Thr278/739 | JNK1 | Increase Sp1 protein stability | [28] |
 | Thr453/739 | P42/p44 MAPK | Enhance VEGF expression | [29] |
 |  | ERK1/2 | Repress PDGFR-α transcription | [30] |
 |  | ERK1/2 | Inhibit RECK expression and promote cell invasion | [31] |
 | Ser641 | PI3K/PKCζ | Increase luteinizing hormone receptor (LHR) transcription | [32] |
 | Thr668 | CKII | Decreased Sp1 DNA binding acticity | [23] |
 | Thr668/Ser670/Thr681 | PKCζ | Increase PDGF transcription | [24] |
 | Thr739 | CDK1 | Decrease Sp1 binding activity | [22] |
Sumoylation | Lys16 | Sumo-1 | Enhance Sp1 degradation | |
Methylation | ND | ND | Recruit Suv39H1 and HDAC1 to induce chromatin remodeling | [35] |
Acetylation | Lys703 | P300 | Recruit HDAC1 and p300 to the promoter of the 12(S)-lipoxygenase | [36] |
Glycosylation | Leu56/57 | ND | Sp1 degradation | [37] |
 | Ser612/641/698/702, Thr640 | ND | Regulate transcriptional activity of Sp1 | [38] |